Alphabet Inc. (GOOGL)’s Isomorphic Labs to Begin Clinical Trials for AI-Designed Drugs, Targeting Faster Drug Discovery
We recently compiled a list of the 10 AI News You Should Not Miss. In this article, we are going to take a look at where ...
Google's DeepMind eyes clinical trials for AI-designed drugs in 2025 - report
Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year.
The Next Web5d
Europe accelerates AI drug discovery as DeepMind spinoff targets trials this year
Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...
DeepMind’s Hassabis Sees AI-Designed Drug Trials This Year
Google DeepMind spinoff Isomorphic Labs expects research of drugs it designed using artificial intelligence will begin this ...
Seeking Alpha5d
Wall Street Lunch: AI-Designed Drugs Expected To See Trials This Year
Isomorphic Labs aims to start clinical trials for AI-designed drugs by year-end, potentially revolutionizing drug discovery timelines. Market optimism persists under Trump 2.0, with a focus on big ...
ReadWrite4d
Trials of drugs developed with AI could begin this year, Google DeepMind CEO says
The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.
AI-developed drug will be in trials by year-end, says Google’s Hassabis
Isomorphic was spun out of Google’s AI research arm Google DeepMind in 2021, but remains a wholly owned subsidiary of its ...